» Articles » PMID: 24629334

Human Viral Oncogenesis: a Cancer Hallmarks Analysis

Overview
Publisher Cell Press
Date 2014 Mar 18
PMID 24629334
Citations 331
Authors
Affiliations
Soon will be listed here.
Abstract

Approximately 12% of all human cancers are caused by oncoviruses. Human viral oncogenesis is complex, and only a small percentage of the infected individuals develop cancer, often many years to decades after the initial infection. This reflects the multistep nature of viral oncogenesis, host genetic variability, and the fact that viruses contribute to only a portion of the oncogenic events. In this review, the Hallmarks of Cancer framework of Hanahan and Weinberg (2000 and 2011) is used to dissect the viral, host, and environmental cofactors that contribute to the biology of multistep oncogenesis mediated by established human oncoviruses. The viruses discussed include Epstein-Barr virus (EBV), high-risk human papillomaviruses (HPVs), hepatitis B and C viruses (HBV and HCV, respectively), human T cell lymphotropic virus-1 (HTLV-1), and Kaposi's sarcoma herpesvirus (KSHV).

Citing Articles

BRN3A, a transcription factor, regulates the expression of genes involved in biological processes shaping the HPV induced cervical cancer.

Prakash A, Patel Y, Roy J Genes Genomics. 2025; .

PMID: 39873931 DOI: 10.1007/s13258-025-01620-3.


A Landscape of Cancer Initiation and Cancer Stem Cells.

Seno M Cancers (Basel). 2025; 17(2).

PMID: 39857984 PMC: 11764454. DOI: 10.3390/cancers17020203.


Mouse models of Kaposi sarcoma-associated herpesvirus (KSHV).

Shifflett K, Dittmer D Virology. 2025; 603:110384.

PMID: 39837218 PMC: 11788063. DOI: 10.1016/j.virol.2024.110384.


Identifying the key regulators orchestrating Epstein-Barr virus reactivation.

Wang Y, Yu J, Pei Y Front Microbiol. 2024; 15:1505191.

PMID: 39703703 PMC: 11655498. DOI: 10.3389/fmicb.2024.1505191.


The Role of microRNA Expression and DNA Methylation in HPV-Related Cervical Cancer: A Systematic Review.

Pulliero A, Cassatella G, Astuni P, Khalid Z, Fiordoro S, Izzotti A Int J Mol Sci. 2024; 25(23).

PMID: 39684425 PMC: 11641737. DOI: 10.3390/ijms252312714.


References
1.
Martinez-Pastor B, Cosentino C, Mostoslavsky R . A tale of metabolites: the cross-talk between chromatin and energy metabolism. Cancer Discov. 2013; 3(5):497-501. PMC: 3652636. DOI: 10.1158/2159-8290.CD-13-0059. View

2.
Schiller J, Lowy D . Vaccines to prevent infections by oncoviruses. Annu Rev Microbiol. 2010; 64:23-41. PMC: 6264788. DOI: 10.1146/annurev.micro.112408.134019. View

3.
Nakamura H, Li M, Zarycki J, Jung J . Inhibition of p53 tumor suppressor by viral interferon regulatory factor. J Virol. 2001; 75(16):7572-82. PMC: 114992. DOI: 10.1128/JVI.75.16.7572-7582.2001. View

4.
Karki R, Lang S, Means R . The MARCH family E3 ubiquitin ligase K5 alters monocyte metabolism and proliferation through receptor tyrosine kinase modulation. PLoS Pathog. 2011; 7(4):e1001331. PMC: 3072377. DOI: 10.1371/journal.ppat.1001331. View

5.
Brechot C . Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology. 2004; 127(5 Suppl 1):S56-61. DOI: 10.1053/j.gastro.2004.09.016. View